Europe Brucellosis Vaccines Market, led by several prominent companies, plays a crucial role in addressing brucellosis, a contagious disease affecting both livestock and humans. These firms, known for their rich histories and innovative strategies, have developed advanced vaccines that mitigate the impact of brucellosis in Europe. In Europe, the contributions of these leading companies are diverse, impacting public health and economic stability. By providing effective vaccines, they enhance livestock health, which is vital for sustaining agricultural productivity across the continent. Since livestock farming significantly contributes to the European economy, healthier herds lead to increased production of meat, milk, and other animal products, thus bolstering food security and the livelihoods of many farming communities.
Additionally, these companies invest in local economies by promoting knowledge transfer and workforce development. They offer training programs and collaborate with European institutions to enhance the technical skills of local professionals in vaccine management and disease prevention. These initiatives empower local communities and foster long-term economic growth, strengthening resilience against zoonotic diseases The strategic expansion and integration of these firms into the European market not only assist in combating brucellosis but also exemplify a sustainable approach to leveraging global expertise for regional development, addressing both health and economic disparities within the continent. As per 6Wresearch, Europe Brucellosis Vaccines Market is projected to grow at a significant CAGR of 9% from 2024-2030F.
Company Name | Boehringer Ingelheim |
Established Year | 1885 |
Headquarters | Ingelheim, Germany |
Official Website | Click Here |
Boehringer Ingelheim is a prominent research-oriented pharmaceutical firm committed to enhancing both human and animal health. Its extensive portfolio includes prescription drugs, over-the-counter products, and veterinary medicines, with a strong focus on innovation and sustainability. The company aims for advancements in fields such as respiratory diseases, oncology, and animal health.
Company Name | Virbac |
Established Year | 1968 |
Headquarters | Carros, France |
Official Website | Click Here |
Virbac is an international animal health firm that has been addressing the needs of pets and livestock since 1968. With a significant emphasis on research and development, Virbac has established itself as a leader in brucellosis prevention through its groundbreaking vaccines.
Company Name | Elanco |
Established Year | 1954 |
Headquarters | - |
Official Website | Click Here |
Elanco Animal Health has a longstanding tradition of providing innovative solutions for animal health, serving both companion animals and livestock. Their offerings include vaccines for brucellosis and various other diseases that impact the health and welfare of animals.
Company Name | Zoetis |
Established Year | 1952 |
Headquarters | Parsippany, New Jersey |
Official Website | Click Here |
Zoetis is a worldwide animal health company that has been addressing the needs of animals for more than 65 years. They provide an extensive array of products and services aimed at enhancing the health and well-being of both companion animals and livestock.
Company Name | Merck Animal Health |
Established Year | 1891 |
Headquarters | Madison, New Jersey |
Official Website | Click Here |
Merck is a global pharmaceutical company with a legacy of over 130 years in animal health. They offer various products and services aimed at enhancing animal health and well-being, including well-known vaccines for brucellosis and other diseases.
Company Name | Ceva Santé Animale |
Established Year | 1999 |
Headquarters | Libourne, France |
Official Website | Click Here |
Ceva Santé Animale is an international animal health firm dedicated to creating products for livestock and poultry. Emphasizing sustainability and innovation, the company provides a variety of vaccines and solutions aimed at enhancing animal health and welfare.
Company Name | IDT Biologika |
Established Year | 1921 |
Headquarters | Dessau, Germany |
Official Website | Click Here |
IDT Biologika is a worldwide biopharmaceutical company with nearly a century of experience. It specializes in the development of vaccines and biologics, including those aimed at preventing brucellosis.
Company Name | Biogenesis Bagó |
Established Year | 1934 |
Headquarters | Bogotá, Colombia |
Official Website | Click Here |
Biogenesis Bagó is an international animal health company with more than 85 years of experience. It focuses on delivering veterinary vaccines and various solutions to enhance the health and welfare of animals.
Company Name | HIPRA |
Established Year | 1971 |
Headquarters | Amer, Spain |
Official Website | Click Here |
HIPRA is an international animal health company with more than 50 years of experience in creating innovative solutions for disease prevention and treatment in animals. The company provides various products, including vaccines for brucellosis.
Company Name | Bayer Animal Health |
Established Year | 1863 |
Headquarters | Leverkusen, Germany |
Official Website | Click Here |
Bayer is a global animal health company with over 150 years of experience, delivering innovative solutions for disease prevention and treatment in animals, including advancements in brucellosis vaccines.